Comb Coherence Transfer (CCT) uses a feed-forward frequency correction to transfer the optical phase of a frequency comb to the beam of a free-running diode laser. This allows the amplification of a selected comb tooth by 50 dB while adding agile and accurate frequency tuning. In the present work, SI-traceable frequency calibration and comb tooth narrowing down to 20 kHz is additionally provided by comb frequency locking to an ultrastable optical frequency reference distributed from Paris to Grenoble through the RENATER optical fiber network [Lisdatet al Nat. Commun, 2016, 7, 12443].
We apply this CCT broadly tunable source for saturated cavity ring-down spectroscopy of ro-vibrational R0 to R10 multiplets in the 2 3 band of 12 CH 4 (from 6015 to 6115 cm-1).
Indeed, efficient cavity injection with large intra-cavity power build-up induces saturation of the ro-vibrational transitions at low pressure and Doppler-free Lamb dips are observed with high signal/noise.
kHz-accurate transition frequencies are derived improving by three orders of magnitude previous values from spectra in the Doppler regime, which are strongly affected by line blending.
While previous saturation spectroscopy investigations addressed specific 2 3 multiplets (R6 or R9), the CCT approach allowed for a rapid coverage Gentaur TraceableGO of the entire R0-R10 series. Measured transition frequencies are compared with experimental and theoretical line lists available in the literature.
The molecular pathophysiology of mood disorders: From the analysis of single molecular layers to multi-omic integration
Next-generation sequencing now enables the rapid and affordable production of reliable biological data at multiple molecular levels, collectively referred to as “omics”. To maximize the potential for discovery, computational biologists have created and adapted integrative multi-omic analytical methods.
When applied to diseases with traceable pathophysiology such as cancer, these new algorithms and statistical approaches have enabled the discovery of clinically relevant molecular mechanisms and biomarkers. In contrast, these methods have been much less applied to the field of molecular psychiatry, although diagnostic and prognostic biomarkers are similarly needed. In the present review, we first briefly summarize main findings from two decades of studies that investigated single molecular processes in relation to mood disorders. Then, we conduct a systematic review of multi-omic strategies that have been proposed and used more recently.
We also list databases and types of data available to researchers for future work. Finally, we present the newest methodologies that have been employed for multi-omics integration in other medical fields, and discuss their potential for molecular psychiatry studies.
Keywords: Bipolar disorder; Epigenetics; Genomics; Major depressive disorder; Mood disorders; Multi-omics; Transcriptomics.
SI-traceable purity assignment of volatile material ethylbenzene by quantitative nuclear magnetic resonance spectroscopy
In this study, a quantitative nuclear magnetic resonance (qNMR) method was developed to assign the SI-traceable purity of ethylbenzene, a volatile material, which is a colorless flammable liquid hydrocarbon at room temperature. An ethanol certified reference material having a similar boiling point was used as an internal standard to avoid measurement error arising from the volatilization of ethylbenzene.
The reference value of the ethylbenzene study material was obtained by the mass balance method by subtracting all the impurities including water, inorganic impurities, and structurally related impurities (e.g. acetophenone, benzene, isobutylbenzene, sec-butylbenzene, methylcyclohexane), which is regarded as the traditional approach for purity assignment for organic compounds. The results of qNMR showed that the purity of the ethylbenzene study material was 998.6 ± 3.8 mg/g at a 95% confidence interval, which was consistent with the reference value of 998.9 ± 1.3 mg/g.
Breaking the ageing paradigm in endometrium: endometrial gene expression related to cilia and ageing hallmarks in women over 35 years
Summary answer: Using unsupervised artificial intelligence methods, we report for the first time that endometrial gene expression changes from 35 years of age in women.
What is known already: Female fertility declines with age, largely attributed to declining oocyte quality and ovarian reserve. Combined with other evidence, a longstanding paradigm holds that age does not affect the endometrial function and age has not been controlled for properly in endometrial studies.
Study design, size, duration: A retrospective in silico analysis was performed of endometrial transcriptomic data from the Gene Expression Omnibus (GEO) sample repository for 27 women of different ages. Results were validated in an independent gene expression dataset of 20 endometrial samples from women aged 23-43 years.
Participants/materials, setting, methods: A systematic search was performed in GEO from October 2016 to January 2019 to identify transcriptomic studies involving women of different ages. Included samples were from norm-ovulatory, women of reproductive age (23-49 years) with regular menstrual cycles who were free of endometriosis and used as controls in a previous endometrial study.
We used raw gene expression data and metadata from these samples to investigate the effect of age on endometrial gene expression. Files were downloaded, pre-processed and explored for potential confounding variables and outliers. Artificial intelligence methods were applied to define age groups, and differential expression and functional analyses were applied to demonstrate and understand the effect of age on gene expression at the molecular level. Functional results were validated in an independent gene expression dataset of 20 endometrial samples from women aged 23-43 years.
Main results and the role of chance: Analysis of the initially retrieved endometrial datasets revealed the age of participants was not available (33.33%) or traceable (43.33%) in most studies. However, one study was suitable for age analysis (GSE4888, n = 27, 23-49 years). Samples showed different transcriptomic profiles according to age, beginning at 35 years. A total of 5778 differentially expressed genes and 27 significantly altered endometrial functions (false discovery rate (FDR) < 0.05) were associated with endometrial gene expression changes related to age. Interestingly, 81.48% of affected functions were related to up-regulation of ciliary processes, with 91 genes involved in cilia motility and ciliogenesis. Other functions included dysregulation of the vascular endothelial growth factor signalling pathway and inhibition of epithelial proliferation triggered by 37 genes involved in cell cycle arrest, angiogenesis, insulin signalling and telomere protection. These findings were validated in an independent dataset using a non-targeted approach; 20 up-regulated ciliary processes (FDR < 0.02) and 6 down-regulated functions related to cell cycle arrest were identified as affected by age, among other hallmarks of ageing such as DNA repair inhibition or sugar metabolism (FDR < 0.05).
Large scale data: Data underlying this article are available in GEO, IDs: GSE4888 (main dataset) and GSE102131 (validation dataset).
Limitations, reasons for caution: This study is limited in size, as are most studies of endometrial transcriptomics where whole-transcriptome analysis considers nearly 22 000 variables in a relatively small population. Yet, our study includes a main sample set and subsequent validation set that enhances reproducibility of our results and provides reasonable evidence for concluding that age affects endometrial gene expression. A larger study prospectively controlling for patient characteristics is needed to accurately describe changes related to age, with a higher sample size and across a wide age range. Additional studies also are necessary to determine the endometrial ageing contribution to infertility for ultimate translation to a clinical setting.
Wider implications of the findings: Our findings support an influence of age on the endometrium in a genome-wide functional approach, breaking the endometrial ageing paradigm in human reproduction. To our knowledge, this work is the first to identify, using a genome-wide functional non-targeted approach, ciliary processes as the primary dysregulated function associated with maternal age. These results should guide the research community to control for age as a potential confounding variable in endometrial gene expression studies and to consider endometrial ageing in further studies as a potential cause of infertility in the clinical setting. The reported functional dysregulations could contribute to diminished embryo implantation with age and further studies will demonstrate if such dysregulation underlies some cases of implantation failure. Additionally, the discovery of these functional alterations could enable mechanistic studies, particularly around the age-related increase in uterine pathologies.
Study funding/competing interest(s): This research was funded by the Instituto de Salud Carlos III through Miguel Servet programme (CP20/00118) granted to Patricia Diaz-Gimeno (Spanish Government) co-funded by FEDER; and by IVI Foundation (1706-FIVI-041-PD). A.D.-P. (FPU/15/01398) and A.P.-L. (FPU18/01777) are granted by the pre-doctoral programme fellowship from the Ministry of Science, Innovation and Universities (Spanish Government). The authors do not have any competing interests to declare.
Trial registration number: N/A.
50ml TC Tubes, Conical, 440 units/box
|04-5540150||Gentaur Genprice||440 units/box||71 EUR|
GMP IL4, 50µg
|04-GMP-HU-IL4-50UG||Gentaur Genprice||50µg||483 EUR|
SDS-Blue™ - Coomassie based solution for protein staining in SDS-PAGE
rHu IL 2 , 3MIU
|04-RHIL2-02F01||Gentaur Genprice||1 vial||249 EUR|
rHu IL 2 , 3MIU , Lot 200908F02
|04-RHIL2-08F02||Gentaur Genprice||1 vial||249 EUR|
PRE-GMP rHu GM-CSF, Molgramostim-Leukoma
|04-RHUGM-CSF-7A10||Gentaur Genprice||300 µg||385 EUR|